Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN gel implant surgery: 1-year results
Journal of Glaucoma Feb 11, 2018
Mansouri K, et al. - In glaucoma patients, the safety and efficacy of XEN gel implant (Allergan Inc., Irvine) between a standalone and combined XEN-Phacoemulsification surgery (XEN+cataract) were assessed by the experts. Safe and sustained IOP reduction after 1 year, was yielded via the XEN gel implant as a standalone procedure or combined with cataract surgery.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
